“…Several studies utilized the variable merozoite surface antigens of B. bovis as a genetic marker to show the existence of variant strains in different geographic regions around the world (Berens et al, 2005;Leroith et al, 2005;Simking et al, 2013;Sivakumar et al, 2013;Tattiyapong et al, 2014). Blood-derived live attenuated B. bovis vaccines are currently used to control babesiosis in Australia, South Africa, Argentina, Brazil, and Israel (Pipano et al, 2002;Shkap et al, 2005Shkap et al, , 2007Gohil et al, 2013). Although the attenuated vaccines generally provide protection against the disease, babesiosis can occur in vaccinated animals as a result of infection with heterologous isolates (Bock et al, 1992(Bock et al, , 1995.…”